24 January 2017
News and Views
Links and Services
The latest issue of the Scandanavian Journal of Gastroenterology reviews whether levofloxacin-based triple therapy is an alternative for first-line eradication of Helicobacter pylori.
Dr Guo-Xin Zhang and colleagues from China evaluated the available data on the e
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors